Botox and dermal fillers treat different causes of facial aging. Botox reduces targeted muscle contraction to soften movement-related wrinkles, while dermal fillers add or restore tissue volume. The right treatment depends on whether muscle activity, volume loss, facial contour, or multiple factors cause the concern.

Botox and fillers are injectable aesthetic treatments, but they are not interchangeable. Botox Cosmetic is a prescription botulinum toxin drug containing onabotulinumtoxinA. Dermal fillers are injectable medical devices made from materials such as hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, and polymethylmethacrylate. Botox treatment in NYC is used for muscle-driven aesthetic concerns, while dermal fillers address volume-related and structural facial changes.

Treatment selection starts with anatomy. Muscle-driven lines favor Botox. Volume loss, folds, or contour deficits favor fillers. When both muscle activity and volume loss contribute to the same facial concern, Botox and dermal fillers can be combined within one treatment plan.

What Are The Difference Between Botox and Fillers?

Botox reduces targeted muscle activity to soften movement-related wrinkles, while dermal fillers add or restore soft-tissue volume to improve folds, fullness, and facial contours. Botox is measured in units; fillers are measured in milliliters or syringes and address different anatomical causes.

The central difference is anatomical: Botox changes muscle activity, while fillers change soft-tissue volume or structure. A movement-related wrinkle therefore matches Botox’s mechanism, while lost volume or inadequate facial projection matches the mechanism of dermal fillers.

What Is Botox and How Does It Work?

Botox is a prescription botulinum toxin medicine containing onabotulinumtoxinA. It blocks acetylcholine release at the neuromuscular junction, temporarily reducing contraction of targeted facial muscles. Lower muscle activity softens dynamic wrinkles such as frown lines, forehead lines, and crow’s feet.

Botox Cosmetic contains onabotulinumtoxinA, a botulinum toxin type A product. It acts on nerve-to-muscle signaling instead of adding volume beneath the skin. The FDA classifies BOTOX Cosmetic as an acetylcholine release inhibitor and neuromuscular blocking agent. For glabellar lines, the FDA-approved treatment uses 20 Units across 5 injection sites, with 4 Units at each site in the corrugator and procerus muscles. The neuromuscular effect begins approximately 1–2 days after injection and increases during the first week.

Botox does not replace lost facial volume, enlarge the lips, or add structural projection to the cheeks or chin. Those changes require a volume-based treatment such as dermal filler.

What Are Dermal Fillers and How Do They Work?

Dermal fillers are injectable medical devices placed beneath the skin to add or restore volume, smooth selected facial folds, and enhance facial contours. Common materials include hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and polymethylmethacrylate (PMMA). Hyaluronic acid fillers place a gel within tissue that adds physical volume and binds water. Added volume can restore cheek fullness, increase lip volume, soften selected folds, or improve chin and jawline contour.

Calcium hydroxylapatite adds structural volume. Poly-L-lactic acid produces a more gradual tissue response associated with collagen formation. Fillers address volume-related and structural concerns such as flattened cheeks, reduced lip fullness, facial folds, deficient chin projection, and reduced jawline definition. Resulting changes depend on the material, treatment area, injection depth, and volume used. Fillers do not reduce nerve signals responsible for muscle contraction. Botox changes muscle activity; fillers change soft-tissue volume or structure.

What Are the Types of Dermal Fillers?

The main FDA-recognized filler materials are hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, and polymethylmethacrylate microspheres. They differ in composition, onset, duration, reversibility, and tissue behavior.

Hyaluronic acid is the broadest commercial filler family. Juvéderm includes products such as Voluma XC, Vollure XC, Volbella XC, and Volux XC. Restylane also includes multiple formulations for different anatomical indications. A product’s membership in a filler family does not mean it is approved for every facial area. FDA approval is product- and site-specific. Sculptra is a poly-L-lactic acid dermal filler, not a separate injectable category. Bellafill contains PMMA microspheres and represents an FDA-approved nonabsorbable filler material.

Botox vs Fillers: What Areas and Concerns Do they Treat? 

Botox areas on the face are selected according to the muscles responsible for the visible concern. Botox targets concerns driven by excessive or repeated muscle contraction, while fillers target volume deficits, folds, and contour changes. Treatment area alone does not determine the injectable; the underlying anatomical cause does.

As of August 2026, FDA-approved BOTOX Cosmetic indications include glabellar lines, lateral canthal lines, forehead lines, and platysma bands associated with activity of their respective muscles. Other aesthetic applications, including masseter reduction, gummy-smile treatment, lip-flip techniques, and certain lower-face applications, have different regulatory status and treatment considerations.

FDA-approved dermal filler uses vary by product and include facial wrinkles and folds, lip fullness, cheek augmentation, chin projection, under-eye hollows, jawline definition, hand volume, HIV-associated facial fat loss, and selected cheek acne scars.

Who Is a Good Candidate for Botox vs Fillers?

Good candidates for Botox have facial lines or contour concerns driven primarily by muscle activity, while good candidates for fillers have volume loss, folds, reduced fullness, or structural contour deficits. Treatment selection depends on facial anatomy, medical history, treatment goals, product indication, and contraindications.

Who Is a Good Candidate for Botox?

Good candidates for Botox include adults who:

• Have dynamic wrinkles that become more visible during facial movement, including frowning, squinting, smiling, or raising the eyebrows.
• Have glabellar lines caused by contraction of the corrugator and procerus muscles.
• Have forehead lines associated with frontalis muscle activity.
• Have crow’s feet associated with contraction of the orbicularis oculi muscles.
• Have platysma bands associated with platysma muscle activity.
• Want to reduce targeted muscle activity without adding facial volume.
• Have realistic treatment goals and understand that Botox produces a temporary reduction in muscle contraction.
• Have no contraindication to the selected botulinum toxin product.

BOTOX Cosmetic is indicated for adults, with FDA-approved cosmetic indications covering specific muscle-related facial and neck concerns.

Who Is a Good Candidate for Fillers?

Good candidates for dermal fillers include adults who:

• Have facial volume loss, including reduced cheek fullness or age-related volume changes.
• Have reduced lip fullness or want to modify lip shape and volume.
• Have facial folds that benefit from soft-tissue augmentation.
• Have deficient chin projection that requires additional structural volume.
• Have jawline contour deficits that can be addressed through soft-tissue augmentation.
• Want to restore or add volume without reducing facial muscle activity.
• Have anatomy and treatment goals that match the indication of the selected filler product.
• Have no active infection, inflammation, or product-specific contraindication in the planned treatment area.

FDA-approved dermal filler indications apply to adults 22 years of age and older, although eligibility depends on the specific filler product, anatomical area, and approved indication.

What Results Can You Expect ?

Botox Before And After Photos

Botox before-and-after results show reduced prominence of muscle-driven lines without added facial volume. Filler results show changes in fullness, contour, projection, or fold depth.

Botox results are best compared using matching facial expressions. For example, glabellar treatment is easier to evaluate when both photographs show maximum frowning. Filler results are best compared using consistent head position, camera distance, lighting, and expression because cheek, lip, chin, and jawline treatments primarily alter three-dimensional contour.

Dermal Fillers Before And After Photos

How Soon Do Botox and Fillers Work?

Botox begins altering targeted neuromuscular activity approximately 1–2 days after injection, with visible changes developing during the first week. Most gel-based fillers create immediate or near-immediate volume, while poly-L-lactic acid fillers such as Sculptra develop more gradually.

Hyaluronic acid and calcium hydroxylapatite fillers create immediate structural volume because material occupies tissue at injection, although early swelling may temporarily affect appearance. The American Academy of Dermatology lists visible PLLA results at approximately 2–3 weeks. Sculptra labeling also explains that early fullness partly reflects reconstitution fluid and swelling that later subsides.

Which Lasts Longer Botox vs Fillers?

Most dermal fillers last longer than BOTOX Cosmetic. Botox duration for glabellar lines is approximately 3–4 months, while filler duration ranges from about 6 months to 2 years or longer depending on the material, product, treatment area, injection technique, and tissue response.

The Botox duration listed in FDA labeling for glabellar lines is approximately 3–4 months. Muscle activity gradually returns as the neuromuscular effect declines, which causes movement-related lines to become visible again over time. BOTOX Cosmetic labeling also states that the safety and effectiveness of treatment more frequently than every 3 months have not been clinically evaluated.

Dermal filler longevity differs substantially by filler material:

• Hyaluronic acid: approximately 6–12 months
• Calcium hydroxylapatite: approximately 18 months
• Poly-L-lactic acid: up to 2 years
• PMMA microspheres: nonabsorbable

Individual filler products can persist longer than these broad material estimates. For example, 67.1% of evaluated subjects treated with Juvéderm Voluma XC remained responders at 24 months in its cheek augmentation study. Filler longevity therefore cannot be reduced to one universal number. Botox has a shorter and more predictable treatment cycle, while filler duration varies more widely according to material, formulation, anatomical location, and product-specific clinical data.

How Many Units of Botox vs Fillers Are Required?

Botox and fillers use different measurement systems, so no direct Botox-to-filler conversion exists. Botox dosage is measured in product-specific units, while dermal filler quantity is measured in milliliters (mL). The amount required depends on the treatment area, anatomy, product, and treatment objective.

These figures represent FDA-labeled BOTOX Cosmetic doses, not universal doses for every botulinum toxin product. Botox dosage changes according to the treatment area and cannot be directly converted to Dysport, Xeomin, Jeuveau, Daxxify, or another botulinum toxin product because each uses product-specific potency units.

Dermal filler quantity is recorded in milliliters (mL) rather than units. The required volume varies according to the anatomical deficit, filler material, product characteristics, injection plane, and desired degree of correction.

What Are the Risks and Side Effects of Botox vs Fillers?

Botox and dermal fillers have different risk profiles. Botox side effects primarily involve injection-site reactions and unwanted muscle weakness, while filler side effects include swelling, bruising, and tissue reactions. Fillers also carry a rare but serious risk of accidental injection into a blood vessel.

Botox Risks and Side Effects

BOTOX Cosmetic side effects depend on the treatment area, dose, injection location, and surrounding muscles. FDA clinical trials report different adverse-event rates for glabellar lines, forehead lines, and lateral canthal lines.

The boxed warning requires context. FDA labeling states that no definitive serious adverse-event reports of distant toxin spread have been associated with dermatologic BOTOX/BOTOX Cosmetic use at the labeled doses of 20 Units for glabellar lines, 24 Units for lateral canthal lines, 40 Units for forehead plus glabellar lines, 44 Units for glabellar plus lateral canthal lines, or 64 Units when all 3 areas are treated together.

Dermal Filler Risks and Side Effects

Dermal filler risks differ by filler material, anatomical location, injection depth, product, and technique. The FDA separates filler complications into common, less common, and rare events rather than assigning one percentage to all dermal fillers.

Sudden vision changes, unusual severe pain, white, gray, or blue skin near the filler injection site, difficulty speaking, facial weakness, or other stroke symptoms require immediate medical attention. The FDA identifies these findings as warning signs of possible accidental intravascular filler injection.

Which Is Safer Botox Vs Filler?

Neither treatment is categorically safer in every patient or anatomical area. Botox carries pharmacologic risks related to neuromuscular weakening and toxin spread, while fillers carry anatomical and vascular risks associated with material placement.

Botox safety depends on authentic product sourcing, correct dose, injection location, medical history, and neuromuscular anatomy. The source states that in November 2025, the FDA warned companies marketing unapproved or misbranded botulinum toxin products after reports involving unapproved products and botulism symptoms.

Filler safety depends heavily on product selection, vascular anatomy, injection depth, technique, and complication management. The FDA advises patients to use licensed healthcare providers familiar with filler anatomy, injection technique, and complication management.

Can Botox or Fillers Be Reversed?

Botox has no injectable antidote that immediately reverses its cosmetic effect. Hyaluronic acid fillers can be enzymatically degraded with hyaluronidase, although aesthetic filler dissolution is an off-label clinical use. Non-HA fillers such as Sculptra, Radiesse, and Bellafill do not dissolve with hyaluronidase.

Botox effects decline as neuromuscular signaling recovers. Hyaluronidase breaks down hyaluronic acid and is used clinically to reduce or remove HA-based fillers. Research has demonstrated degradation of products including Juvéderm, Restylane, and Belotero after hyaluronidase exposure. Calcium hydroxylapatite, poly-L-lactic acid, and PMMA do not respond to hyaluronidase because they are not hyaluronic acid. Reversibility depends on the specific filler material, not the filler category as a whole.

What Is the Downtime?

Botox has no required recovery period, and normal activities can resume immediately. Fillers also allow most patients to return to daily activities quickly, although swelling, redness, tenderness, or bruising can remain visible longer.

The American Society of Plastic Surgeons states that botulinum toxin injections require no downtime or recovery time. Rubbing or massaging the treated Botox area is discouraged because toxin movement can affect neighboring muscles.

Filler recovery varies by material, site, injected volume, and individual response. The AAD reports that common minor reactions often resolve within 7–14 days or earlier. ASPS recommends avoiding intense physical activity for approximately 24–48 hours to limit swelling and bruising. Downtime and time until the final appearance are different. A patient may return to work while swelling or bruising remains visible.

How Much Do Botox and Fillers Cost?

In New York City, Botox costs about $12–$25+ per unit, while dermal fillers often cost approximately $700–$1,400 per syringe. Total Botox and filler costs depend on the treatment area, amount of product required, injector expertise, filler brand, and Manhattan practice location.

Botox NYC Pricing

Botox NYC pricing varies primarily by the number of units injected. Published 2026 NYC pricing data place Botox at approximately $12–$25+ per unit, with dermatology and premium Manhattan practices often charging toward the upper end of the range.

Published NYC practices also show current Botox prices around $15–$16 per unit, illustrating how individual provider pricing differs across Manhattan.

Dermal Filler Pricing in NYC

Dermal fillers are priced per syringe rather than per unit. Current Manhattan pricing for hyaluronic acid fillers falls around $700–$1,400 per syringe, although specific products and premium practices can exceed this range.

For example, one current NYC practice lists Juvéderm fillers from $700 to $1,200 per syringe, Radiesse at $600 per syringe, and Sculptra at $750 per vial. Another Manhattan practice lists Botox at $15 per unit and filler at $700 per syringe.

The final treatment cost depends on how much Botox or filler is required. Botox cost increases with the number of units, while filler cost increases with the number of syringes or vials. Product choice, anatomical complexity, treatment goals, and injector expertise also affect the final NYC price.

Can Botox and Fillers Be Used Together?

Yes. Botox and fillers can be used in the same facial treatment plan because they change different anatomical components. Botox reduces selected muscle activity, while fillers restore or add tissue volume.

For example, upper-face Botox may be combined with cheek, chin, lip, or lower-face filler. Botox addresses movement; filler addresses structure. Combination treatment does not mean every wrinkle requires both products. One anatomical cause requires a matching mechanism; multiple causes may require multiple mechanisms.

When Are Neither Botox Nor Fillers the Right Treatment?

Neither Botox nor filler matches every sign of facial aging. Botox does not replace structural volume, and fillers do not reposition substantially sagging tissue or directly correct pigmentation and surface damage.

Significant skin and soft-tissue laxity may require structural repositioning. Fillers add volume but do not reproduce the tissue repositioning achieved by a facelift, brow lift, or eyelid surgery.

Pigmentation, rough texture, photodamage, and some superficial lines primarily involve skin quality rather than muscle contraction or missing volume. Resurfacing treatments target these concerns through different mechanisms.

Medical contraindications can also exclude injectable treatment. BOTOX Cosmetic is contraindicated in people with known hypersensitivity to botulinum toxin preparations or infection at the proposed injection site. Filler treatment requires screening for allergies, bleeding disorders, active inflammation, infection, previous filler materials, and product-specific contraindications.

How Does Sculptra Compare With Botox and Hyaluronic Acid Fillers?

Sculptra is a poly-L-lactic acid dermal filler with a gradual biostimulatory treatment pattern. Botox reduces muscle contraction, conventional HA fillers create immediate gel-based volume, and Sculptra produces progressive correction over weeks.

FDA materials describe PLLA as a biodegradable synthetic polymer whose results become increasingly apparent over several weeks and can last up to 2 years.

Sculptra often uses a treatment series. FDA labeling for certain facial indications describes 1–4 treatment sessions, 3, with at least 3 weeks between sessions, although the regimen depends on the approved use and required correction.

Sculptra is a specific non-HA filler subtype, not an unrelated third injectable category.

What Are the Pros and Cons of Botox vs Fillers?

Botox and dermal fillers have different advantages and limitations because they address different anatomical concerns. The benefits of Botox include reducing muscle-driven wrinkles, while dermal fillers restore or add volume. Their disadvantages include the temporary effects of Botox and filler-specific material and vascular risks.

Botox Pros and Cons

Dermal Filler Pros and Cons

The main difference remains anatomical. Botox benefits muscle-driven concerns, while dermal fillers benefit volume-related and structural concerns. Neither treatment replaces the mechanism or function of the other.

Which Should You Choose: Botox or Fillers?

Choose Botox when muscle contraction primarily causes the concern. Choose filler when lost volume, inadequate projection, or structural contour primarily causes it. Consider a combined plan when both mechanisms are present. Choose neither when another anatomical layer or process is responsible.

The deciding question is not whether Botox or filler is better. It is which anatomical mechanism creates the visible concern. Botox changes muscle activity. Fillers change tissue volume or structure.

Frequently Asked Questions

What Happens If You Stop Getting Botox or Fillers?

Stopping treatment allows temporary effects to decline without causing withdrawal. Botox-treated muscles gradually regain activity as neuromuscular signaling recovers. Absorbable fillers progressively lose correction as material is metabolized or tissue effects decline. Facial aging continues.

Does Age Determine Whether Botox or Filler Is Better?

Age alone does not determine treatment selection; anatomy does. People of the same age can differ in muscle activity, facial volume, bone structure, skin quality, and tissue laxity.

FDA approval still establishes age-related regulatory boundaries. FDA-approved filler indications begin at age 22, while BOTOX Cosmetic is indicated for adults.

Are Botox Units the Same as Dysport, Xeomin, or Other Toxin Units?

No. BOTOX Cosmetic units are product-specific and cannot be directly converted into units of other botulinum toxin products.

A treatment described as “20 units” has meaning only when the botulinum toxin product is identified.

Can Previous Fillers Affect Future Injectable Treatments?

Yes. Previous filler material, location, quantity, and treatment date matter when planning future injections.

Hyaluronic acid, calcium hydroxylapatite, PLLA, and PMMA differ in persistence and reversibility. Permanent or long-lasting materials require particular attention because they may remain after the visible cosmetic effect changes.

Can Dermal Fillers Appear on Medical Imaging?

Some filler materials can affect medical imaging. The FDA states that calcium hydroxylapatite filler remains visible on X-rays and can obscure underlying features.

Patients with previous filler treatment should tell medical professionals which filler material was used and where it was injected.